Dander, Erica
Pischiutta, Francesca
Di Marzo, Noemi
Pascente, Rosaria
Panini, Nicolò
Fallati, Alessandra
Biondi, Andrea
Zanier, Elisa R.
D’Amico, Giovanna https://orcid.org/0000-0001-7809-7269
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2019 - ID. 23354, IG 2019 - ID. 23354, IG 2019 - ID. 23354, IG 2019 - ID. 23354)
Beat Leukemia Association (Research Fellowship 2022)
Article History
Received: 6 December 2024
Accepted: 22 May 2025
First Online: 29 May 2025
Declarations
:
: The authors declare no competing interests.
: All experimental procedures involving animals and their care to obtain organotypic cortical brain slices were conducted in accordance with the institutional guidelines at the IRFMN - Istituto di Ricerche Farmacologiche Mario Negri. The IRFMN adheres to the principles set out in the following laws, regulations, and policies governing the care and use of laboratory animals: Italian Governing Law (D.lgs 26/2014; Authorisation n.19/2008-A issued March 6, 2008 by Ministry of Health); Mario Negri Institutional Regulations and Policies providing internal authorization for persons conducting animal experiments (Quality Management System Certificate – UNI EN ISO 9001:2008 – Reg. N° 8576-A); the NIH Guide for the Care and Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC Council Directive 2010/63/UE). They were reviewed and approved by the Mario Negri Institute Animal Care and Use Committee that includes ad hoc members for ethical issues, and by the Italian Ministry of Health (Decreto no. D/07/2013-B).